MedTrace Logo

Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes

NCT00263419 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2011-10-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether a structured stress relief management program can prevent the progression of late diabetic complications in patients with type 2 diabetes.

Conditions

  • Albuminuria
  • Diabetes Mellitus, Type 2
  • Diabetes Complications

Interventions

BEHAVIORAL

Mindfulness Based Stress Reduction

8 weeks mindfulness based stress reduction (MBSR) based on body and meditation practices that aims at cultivation of openness, awareness of the present moment and acceptance of all internal and external experiences. It is assumed that this allows to act more reflectively rather than impulsively.

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Peter P Nawroth, MD · University of Heidelberg, Dept. Medicine 1, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2012-03-31
Completion
2012-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263419 on ClinicalTrials.gov